Evidence map›Paper›PMID 38401480›Full record

ArticleNeoplasia (New York, N.Y.)2024

Corrigendum to "Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition." [Neoplasia Volume 23, Issue 9, September 2021, Pages 1002-1015].

Chinnadurai Mani, Kaushlendra Tripathi, Sandeep Chaudhary, Ranganatha R Somasagara, Rodney P Rocconi, Chiquito Crasto, Mark Reedy, Mohammad Athar, Komaraiah Palle

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neoplasia (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Chinnadurai ManiDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA.
Kaushlendra TripathiDepartment of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, Al, 36904, USA.
Sandeep ChaudharyDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, Al, 35294, USA.
Ranganatha R SomasagaraDepartment of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, Al, 36904, USA.
Rodney P RocconiDepartment of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, Al, 36904, USA.
Chiquito CrastoCenter for BioTechnology and Genomics, Texas Tech University, Lubbock, TX, 79409, USA.
Mark ReedyDepartment of Obstetrics and Gynecology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA.
Mohammad AtharDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, Al, 35294, USA.
Komaraiah PalleDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA; Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA. Electronic address: komaraiah.palle@ttuhsc.edu.
Texas Tech University · USTexas Tech University Health Sciences Center · USUniversity of Alabama at Birmingham · USUSA Mitchell Cancer Institute · USUniversity of South Alabama · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38401480
PMCPMC10906388
OpenAlexW4392135279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.